申请人:——
公开号:US20010023254A1
公开(公告)日:2001-09-20
Impulse Control Disorders (ICD's) are characterized by harmful behaviors performed in response to irresistible impulses. The essential feature of an ICD is the failure to resist an impulse, drive, or temptation and to perform an act that is harmful to the person or to others. The present invention comprises methods for the treatment or prevention of ICD's using a class of sulfamates of the following formula:
1
wherein X is CH
2
or oxygen, and R
1
, R
2
, R
3
, R4 and R
5
are as herein defined. Further, pharmaceutical compositions containing a compound of formula (I) as well as methods for their use and intermediates form part of the present invention are also disclosed.
冲动控制障碍(ICD)的特征为在无法抵制的冲动下进行有害行为。ICD的本质特征是无法抵制冲动、驱动力或诱惑,并执行对个人或他人有害的行为。本发明涉及使用以下公式的磺酰胺类治疗或预防ICD的方法:1其中X为CH2或氧,R1、R2、R3、R4和R5如本文所定义。此外,本发明还揭示了含有公式(I)化合物的制药组合物以及其使用方法和中间体。